Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Blood Plasma Therapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01383928
What this trial is testing

Study of Oral IXAZOMIB in Combination With Lenalidomide and Dexamethasone in Participants With Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
Millennium Pharmaceuticals, Inc. 64
Post-approval studies (Phase 4)Study completedNCT00313937
What this trial is testing

SAM - Skip a Meal - Insulin Glargine, Diabetes Mellitus Type 1

Who this might be right for
Diabetes Mellitus, Type 1
Sanofi 91
Testing effectiveness (Phase 2)Active Not RecruitingNCT03618537
What this trial is testing

Ixazomib Maintenance Study in Patients With AL Amyloidosis

Who this might be right for
AL Amyloidosis
Memorial Sloan Kettering Cancer Center 17
Very early researchStudy completedNCT00017381
What this trial is testing

Monoclonal Antibody Therapy and Peripheral Stem Cell Transplant in Treating Patients With Non-Hodgkin's Lymphoma

Who this might be right for
Contiguous Stage II Adult Diffuse Large Cell LymphomaContiguous Stage II Adult Diffuse Small Cleaved Cell LymphomaContiguous Stage II Grade 1 Follicular Lymphoma+47 more
National Cancer Institute (NCI) 30
Testing effectiveness (Phase 2)Study completedNCT02412228
What this trial is testing

Ixazomib, Cyclophosphamide and Dexamethasone for Multiple Myeloma

Who this might be right for
Multiple Myeloma
John L. Reagan 12
Testing effectiveness (Phase 2)Temporarily pausedNCT06572605
What this trial is testing

External Beam Radiation Therapy in Combination With Talquetamab for the Treatment of Multiple Myeloma Patients With Extramedullary Disease

Who this might be right for
Extramedullary Disease in Multiple MyelomaMultiple Myeloma
City of Hope Medical Center 20
Testing effectiveness (Phase 2)Looking for participantsNCT06758375
What this trial is testing

Low Dose Teclistamab in Newly Diagnosed Multiple Myeloma Patients

Who this might be right for
Multiple Myeloma, Newly Diagnosed
Hospital Universitario Dr. Jose E. Gonzalez 10
Not applicableStudy completedNCT03001128
What this trial is testing

Biomarkers to Predict Time to Plasma HIV RNA Rebound

Who this might be right for
HIV-1 Infection
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections 61
Large-scale testing (Phase 3)UnknownNCT03328871
What this trial is testing

The Combination Therapy of Fractional Laser and PRP Compared With Nanofat Grafting and PRP Synergy in Treating Striae Gravidarum.

Who this might be right for
Treatments of Striae Gravidarum
First Affiliated Hospital of Jinan University 10
Post-approval studies (Phase 4)UnknownNCT04521387
What this trial is testing

Evaluation of Clinical Efficacy of Different Injection Therapies for Treating Humeral Epicondylopathy

Who this might be right for
Elbow Tendinopathy
Wroclaw Medical University 120
Not applicableEnrolling By InvitationNCT04065516
What this trial is testing

ARAT for Reflux Disease After Peroral Endoscopic Myotomy in Patients With Achalasia

Who this might be right for
AchalasiaGastroesophageal Reflux
Coordinación de Investigación en Salud, Mexico 44
Large-scale testing (Phase 3)Active Not RecruitingNCT04459416
What this trial is testing

Managing Pain and Symptom Burden Caused by Chemotherapy in People With Myeloma or Lymphoma

Who this might be right for
Multiple MyelomaHodgkin DiseaseNon-Hodgkin Lymphoma
Memorial Sloan Kettering Cancer Center 299
Early research (Phase 1)Study completedNCT04811898
What this trial is testing

A Dose Escalation Study of LNA-i-Mir-221 for Cancer Treatment

Who this might be right for
Multiple Myeloma, RefractoryHepatocarcinomaAdvanced Solid Tumor
Azienda Ospedaliera Universitaria Mater Domini, Catanzaro 17
Testing effectiveness (Phase 2)Study completedNCT04512287
What this trial is testing

PRP for Treatment of Peyronie's Disease

Who this might be right for
Peyronie DiseaseSexual Dysfunction, PhysiologicalSexual Dysfunction Male+1 more
University of Miami 65
Large-scale testing (Phase 3)Study completedNCT01916252
What this trial is testing

Bortezomib (Velcade®), Lenalidomide (Revlimid®) and IV Busulfan (Busilvex®) in Patients Under 65 Years Old

Who this might be right for
Multiple Myeloma
PETHEMA Foundation 460
Post-approval studies (Phase 4)Study completedNCT01432405
What this trial is testing

Effect Of Exenatide Treatment on Liver Fat Content in Patients With Diabetes

Who this might be right for
Type 2 Diabetes Mellitus
Baylor College of Medicine 24
Testing effectiveness (Phase 2)Study completedNCT00005001
What this trial is testing

Safety and Effectiveness of Treating HIV-Positive Patients With an HIV Vaccine (Remune)

Who this might be right for
HIV Infections
Agouron Pharmaceuticals 40
Not applicableStudy completedNCT00818298
What this trial is testing

24-Hour Time Course of Striatal Dopamine D2 Receptor Occupancy of Ziprasidone: A PET Study

Who this might be right for
SchizophreniaSchizoaffective Disorder
Centre for Addiction and Mental Health 12
Testing effectiveness (Phase 2)Study completedNCT00119392
What this trial is testing

Yttrium Y 90 Ibritumomab Tiuxetan, Fludarabine, Radiation Therapy, and Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

Who this might be right for
B-cell Chronic Lymphocytic LeukemiaNodal Marginal Zone B-cell LymphomaRecurrent Adult Burkitt Lymphoma+14 more
Fred Hutchinson Cancer Center 42
Early research (Phase 1)Study completedNCT01998971
What this trial is testing

JNJ-54767414 (HuMax CD38) (Anti-CD38 Monoclonal Antibody) in Combination With Backbone Treatments for the Treatment of Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Janssen Research & Development, LLC 240
Next Page